Ensysce Biosciences (ENSCW) Cash from Investing Activities (2018 - 2022)

Ensysce Biosciences (ENSCW) has 5 years of Cash from Investing Activities data on file, last reported at $4500.0 in Q1 2022.

• Cash from Investing Activities for Q1 2022 came in at $4500.0, up 107.2% year-over-year; the trailing twelve-month figure through Dec 2022 was $4500.0 (changed N/A YoY), and the FY2022 annual result was $4500.0, changed N/A from the prior year.
• Cash from Investing Activities improved to $4500.0 in Q1 2022 per ENSCW's latest filing, from -$62500.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $183.4 million in Q4 2020 and troughed at -$182.8 million in Q3 2020.
• A 5-year average of $14.0 million and a median of $211519.0 in 2018 frame the typical range for Cash from Investing Activities.
• On a YoY basis, Cash from Investing Activities climbed as much as 88935.13% in 2020 and fell as far as 127049.76% in 2020.
• A 5-year view of Cash from Investing Activities shows it stood at $362773.0 in 2018, then surged by 2995.65% to $11.2 million in 2019, then surged by 1533.16% to $183.4 million in 2020, then sank by 100.03% to -$62500.0 in 2021, then surged by 107.2% to $4500.0 in 2022.
• Business Quant data shows ENSCW's Cash from Investing Activities at $4500.0 in Q1 2022, -$62500.0 in Q1 2021, and $183.4 million in Q4 2020.